Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$158.38M
Total Bought:
$67.95M
Total Sold:
$54.70M
Net Transaction:
+$13.24M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Cogent Biosciences, Inc.(COGT)225,158343,284+118,126$8.67M$13.29M8.39%+$4.62M
Axsome Therapeutics, Inc.(AXSM)11,21753,916+42,699$1.90M$13.20M8.33%+$11.30M
Genmab A/S(GMAB)196,709430,600+233,891$5.28M$11.83M7.47%+$6.55M
Celldex Therapeutics, Inc.(CLDX)180,048287,583+107,535$5.71M$10.70M6.76%+$4.99M
Trevi Therapeutics, Inc.(TRVI)251,566524,224+272,658$3.00M$9.78M6.17%+$6.78M
Revolution Medicines, Inc.(RVMD)051,053+51,053$0$9.56M6.04%+$9.56M
Definium Therapeutics, Inc.(DFTX)351,461188,282-163,179$6.64M$8.86M5.59%+$2.21M
Vir Biotechnology, Inc.(VIR)730,548853,685+123,137$6.55M$8.70M5.49%+$2.15M
Immunovant, Inc.(IMVT)357,606208,368-149,238$8.88M$8.03M5.07%-$854.5K
UroGen Pharma Ltd.(URGN)387,371191,313-196,058$6.96M$7.04M4.45%+$75.4K
CLIMB BIO INC199,209521,082+321,873$1.36M$6.79M4.29%+$5.43M
Adlai Nortye Group Ltd.(ANL)414,852552,501+137,649$2.87M$6.35M4.01%+$3.48M
Savara Inc.(SVRA)1,585,977977,460-608,517$8.66M$6.02M3.80%-$2.64M
MAPLIGHT THERAPEUTICS INC192,139125,432-66,707$3.91M$4.50M2.84%+$589.3K
ORIC Pharmaceuticals, Inc.(ORIC)115,234406,077+290,843$1.46M$4.40M2.78%+$2.94M
United Therapeutics Corporation(UTHR)5,1867,172+1,986$3.08M$3.89M2.45%+$810.8K
Vaxcyte, Inc.(PCVX)110,45466,793-43,661$6.42M$3.88M2.45%-$2.54M
BeOne Medicines AG(ONC)012,273+12,273$0$3.50M2.21%+$3.50M
CABALETTA BIO INC1,066,2391,278,652+212,413$2.87M$3.48M2.20%+$609.8K
Zai Lab Limited(ZLAB)275,818155,813-120,005$5.19M$2.96M1.87%-$2.23M
SIONNA THERAPEUTICS INC141,02463,156-77,868$5.65M$2.78M1.75%-$2.88M
BRIGHT MINDS BIOSCIENCES INC13,31130,456+17,145$971.3K$2.14M1.35%+$1.17M
ACLARIS THERAPEUTICS INC366,490257,675-108,815$1.37M$1.36M0.86%-$11.2K
CYBIN INC0204,424+204,424$0$1.35M0.85%+$1.35M
Kiniksa Pharmaceuticals International, plc(KNSA)018,867+18,867$0$1.21M0.76%+$1.21M
Roivant Sciences Ltd.(ROIV)025,623+25,623$0$906.8K0.57%+$906.8K
TONIX PHARMACEUTICALS HLDG C63,54063,648+108$873.7K$812.1K0.51%-$61.5K
PROTARA THERAPEUTICS INC121,457121,4570$632.8K$464.0K0.29%-$168.8K
FAETH THERAPEUTICS INC014,175+14,175$0$354.4K0.22%+$354.4K
BOUNDLESS BIO INC055,356+55,356$0$138.4K0.09%+$138.4K
BIOMEA FUSION INC250,000250,0000$382.5K$85.3K0.05%-$297.2K
VYNE THERAPEUTICS INC061,269+61,269$0$39.9K0.03%+$39.9K
ARVINAS INC312,6200-312,620$3.31M$0—-$3.31M
CENTURY THERAPEUTICS INC119,3080-119,308$269.6K$0—-$269.6K
Cullinan Therapeutics, Inc.(CGEM)59,4840-59,484$845.3K$0—-$845.3K
IQVIA Holdings Inc.(IQV)25,6680-25,668$4.38M$0—-$4.38M
Oruka Therapeutics, Inc.(ORKA)63,5910-63,591$3.12M$0—-$3.12M
PALATIN TECHNOLOGIES INC35,9690-35,969$626.6K$0—-$626.6K
Pfizer Inc.(PFE)74,0000-74,000$2.08M$0—-$2.08M
Summit Therapeutics Inc.(SMMT)892,8730-892,873$16.93M$0—-$16.93M
Taysha Gene Therapies, Inc.(TSHA)258,2690-258,269$1.15M$0—-$1.15M
Travere Therapeutics, Inc.(TVTX)102,7540-102,754$3.05M$0—-$3.05M
Vertex Pharmaceuticals Incorporated(VRTX)11,0100-11,010$4.92M$0—-$4.92M
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q2 2026 | TickerTrail